---
$id: https://graph.org.ai/products/commodity/51372014
$type: Product
source: UNSPSC
code: "51372014"
title: "Metopon"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metopon

**UNSPSC Code**: 51372014
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C18H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94XZ1CC69D, chemically known as 4,5-alpha-epoxy-3-hydroxy-5,17-diethylmorphinan-6-one but generally known as metopon, which bears US NIH Compound Identifier 5359353. European Medicines Agency schedules Metopon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08909MIG. The term METOPON is an International Non-Proprietary Name. METOPON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metopon under HS 29391900 and SITC 54141. As of Q4 2014, METOPON remains the US FDA Preferred Term for this commodity. Metopon bears US NLM identifiers UMLS ID C0625593 and NCI Concept Code C83963. SMILES: O1C2(C34C(C(N(CC3)C)CC3C4C1C(O)CC3)CCC2=O)C.

